HER2 Support Group Forums

HER2 Support Group Forums (https://her2support.org/vbulletin/index.php)
-   General Cancer News (https://her2support.org/vbulletin/forumdisplay.php?f=45)
-   -   AbbVie doses first subject in adalimumab clinical trial using Halozyme's ENHANZE tech (https://her2support.org/vbulletin/showthread.php?t=64435)

News 01-21-2016 11:11 AM
AbbVie doses first subject in adalimumab clinical trial using Halozyme's ENHANZE tech
 
Halozyme Therapeutics, Inc. today announced that AbbVie has dosed the first subject in a clinical trial evaluating the safety and pharmacokinetics of adalimumab with Halozyme's proprietary ENHANZE technology.

More...


All times are GMT -7. The time now is 02:45 PM.

Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021